Announcement on Convening Performance Briefing for 2025 and Q1 2026
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
Announcement on Convening Performance Briefing for 2025 and Q1 2026
Filed with SSE · · 2 pages · Chinese
Release
Chimin Health Management Co., Ltd. on 6ix
Earlier from Chimin Health Management
- Announcement on Termination of the Controlling Shareholder's Agreement to Transfer Shares
- Announcement on Estimated Daily Related Party Transactions in 2026
- Announcement on Termination of Capital Increase for Share Expansion by Wholly-owned Subsidiary
- Indicative Announcement on Changing the Disclosure Date of the 2025 Annual Report
- Announcement on Obtaining Notice of Approval for Drug Clinical Trial by the Holding Subsidiary’s Pharmaceuticals
Later from Chimin Health Management
- Announcement on Resolutions of the 2025 Annual General Meeting
- Announcement on Notice of Approval for the Transfer of Patent Rights Obtained by Holding Subsidiaries
- Announcement on Outline of the Performance Briefing for 2025 and Q1 2026
- Announcement on the Semi-annual Performance for 2026
- Indicative Announcement on the Share Transfer by Agreement and Changes in Equity Interests of Shareholders
Follow Chimin Health Management into a list and get an email when it puts out news.
Follow Chimin Health Management